1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/57822
Full metadata record
DC FieldValueLanguage
dc.creatorJulia Pereira Afonso Dos Santospt_BR
dc.creatorGabriel Assis Lopes do Carmopt_BR
dc.creatorAndrea Zawacki Beatonpt_BR
dc.creatorTainá Vitti Lourençopt_BR
dc.creatorAdriana Costa Diamantinopt_BR
dc.creatorMaria do Carmo Pereira Nunespt_BR
dc.creatorCraig Sablept_BR
dc.creatorBruno Ramos Nascimentopt_BR
dc.date.accessioned2023-08-14T22:28:21Z-
dc.date.available2023-08-14T22:28:21Z-
dc.date.issued2017-
dc.citation.volume108pt_BR
dc.citation.issue4pt_BR
dc.citation.spage370pt_BR
dc.citation.epage374pt_BR
dc.identifier.doi10.5935/abc.20170047pt_BR
dc.identifier.issn0066782Xpt_BR
dc.identifier.urihttp://hdl.handle.net/1843/57822-
dc.description.resumoRheumatic Heart Disease (RHD) is the cardiac consequence of acute rheumatic fever (ARF), an inflammatory disease triggered by streptococcal pharyngitis. Although the prevalence of RHD has decreased in high-income countries, lack of social and economic development and poor primary prevention – mainly in in low- and middle-income countries – perpetuate an environment where RHD remains endemic. It is estimated that RHD continues to affect nearly 33 million people worldwide.1 According to the World Health Organization (WHO), RHD is responsible for 1-1.5% of all cardiovascular deaths and 3-4% of cardiovascular Disability-Adjusted Life Years (DALYs).2 In Brazil, according to the Unified Health System (SUS), there were 26,054 hospital admissions for ARF (45% with cardiac compromise) between 2008 and 2015, and the total cost to SUS was US$3.5 million, a number that is most likely underestimated.3 The main burden of RHD to public health systems consists of repeated hospital admissions and cardiac surgeries in the following decades after initial cardiac damage. If RHD is detected in its early stages, secondary prophylaxis (regular penicillin injections) can be initiated to prevent new episodes of ARF, avoiding further valve damage and progression of RHD. In high prevalence regions, RHD meets the traditional screening criteria defined by Wilson and Jungner,4 although the long-term clinical significance of latent RHD is not entirely clear. Previous studies have demonstrated, however, that in 38 to 68% of asymptomatic RHD patients, echocardiographic findings show that abnormalities persist, and progress in 4 to 16%,5 reinforcing the importance of early diagnosis in susceptible populations.The PROVAR study (Programa de Rastreamento da Valvopatia Reumática – Rheumatic Heart Disease Screening Program) is the first large-scale echocardiographic screening program in Brazil, using echocardiography to estimate the prevalence of latent RHD in asymptomatic children between 5 and 18 years old attending public schools of underserved areas of the cities Belo Horizonte, Montes Claros and Bocaiúva, in the Brazilian State of Minas Gerais. Minas Gerais is the second most populous Brazilian state (>20 million inhabitants) and has a large territory, great geographical diversity and is marked by economic discrepancies between its different regions. This project is a clinical and research collaboration between the University Hospital of Universidade Federal de Minas Gerais (UFMG), Brazil, and the Children’s National Health System (CNHS) in Washington DC, United States of America (USA).pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofArquivos Brasileiros de Cardiologia-
dc.rightsAcesso Abertopt_BR
dc.subjectRheumatic Heart Diseasept_BR
dc.subjectMass Screeningpt_BR
dc.subjectEchocardiographypt_BR
dc.subjectChild Healthpt_BR
dc.subjectAdolescent Healthpt_BR
dc.subject.otherCardiopatia Reumáticapt_BR
dc.subject.otherProgramas de Rastreamentopt_BR
dc.subject.otherEchocardiographypt_BR
dc.subject.otherSaúde da criançapt_BR
dc.subject.otherSaúde do Adolescentept_BR
dc.titleChallenges for the Implementation of the First Large-Scale Rheumatic Heart Disease Screening Program in Brazil: The PROVAR Study Experiencept_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.scielo.br/j/abc/a/yzqNHCsknnhVT4wjjsKMKsv/?lang=enpt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Challenges for the Implementation of the First Large-Scale Rheumatic Heart Disease Screening Program in Brazil pdfa.pdf197.45 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.